Alternatively, our observations could be due to overlap between FCAS and a more severe clinical phenotype such as CINCA/NOMID or the mosaic NLRP3-AIDs, since many mutations are reported in more than one NLRP3-AID. This evidence concerns the gene AICDA and CINCA syndrome.